Sinotherapeutics Inc. (SHA:688247)

Sinotherapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,113	4,355	4,517	4,978	7,593	-
Market Cap Growth	-17.85%	-3.58%	-9.25%	-34.45%	-	-
Enterprise Value	3,347	3,590	3,769	4,194	6,771	-
Last Close Price	9.16	9.70	10.00	10.83	16.44	-
PE Ratio	83.27	91.73	35.37	81.50	81.71	-
PS Ratio	9.21	9.75	8.83	16.60	30.67	-
PB Ratio	3.18	3.37	3.55	4.11	6.45	-
P/TBV Ratio	3.26	3.45	3.66	4.28	6.74	-
P/FCF Ratio	76.49	81.00	127.97	-	-	-
P/OCF Ratio	43.15	45.69	34.69	384.14	103.76	-
EV/Sales Ratio	7.50	8.04	7.37	13.99	27.35	-
EV/EBITDA Ratio	35.83	38.45	27.36	62.24	80.84	-
EV/EBIT Ratio	54.41	58.35	31.55	94.67	116.33	-
EV/FCF Ratio	62.26	66.77	106.79	-	-	-
Debt / Equity Ratio	0	0	0	0	0.00	0.01
Debt / EBITDA Ratio	0.00	0.00	0.00	0.00	0.02	0.04
Debt / FCF Ratio	0	0	0	-	-	0.03
Net Debt / Equity Ratio	-0.58	-0.58	-0.58	-0.62	-0.68	-0.72
Net Debt / EBITDA Ratio	-8.00	-8.00	-5.32	-11.11	-9.62	-4.18
Net Debt / FCF Ratio	-13.88	-13.88	-20.78	28.81	7.81	-3.91
Asset Turnover	0.31	0.31	0.36	0.22	0.23	0.39
Inventory Turnover	3.09	3.09	2.63	2.34	1.96	1.71
Quick Ratio	10.08	10.08	8.19	9.13	9.76	6.21
Current Ratio	11.27	11.27	9.46	10.49	10.59	6.91
Return on Equity (ROE)	3.70%	3.70%	10.29%	5.12%	9.87%	21.29%
Return on Assets (ROA)	2.66%	2.66%	5.31%	2.06%	3.31%	7.41%
Return on Invested Capital (ROIC)	10.07%	10.10%	21.46%	9.84%	19.49%	52.09%
Return on Capital Employed (ROCE)	4.50%	4.50%	8.80%	3.50%	4.70%	12.30%
Earnings Yield	1.15%	1.09%	2.83%	1.23%	1.22%	-
FCF Yield	1.31%	1.23%	0.78%	-0.52%	-1.36%	-
Dividend Yield	0.55%	-	0.62%	0.38%	0.38%	-
Payout Ratio	58.63%	58.63%	21.83%	46.02%	-	-
Buyback Yield / Dilution	5.35%	5.35%	2.92%	-11.22%	-3.32%	-0.21%
Total Shareholder Return	5.90%	5.35%	3.54%	-10.84%	-2.94%	-0.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.